More Ways to Connect
  LinkedIn Twitter YouTube Instagram
Beth Sininger

Beth Sininger

Olugbenga Olowokure, MD, specializes in gastrointestinal oncology.

Syed Ahmad, MD

Michelle Mierzwa, MD
Back Next
Publish Date: 08/16/12
Media Contact: AHC Public Relations, (513) 558-4553
Patient Info: For hematology oncology, call 513-584-8500. For surgical oncology, call 513-584-8900. For radiation oncology, call 513-584-4775 (Clifton) or 513-475-7777 (West Chester). 
PDF download
RSS feed
related news
share this
Patient Lives Beyond Pancreatic Cancer With Innovative Care Regimen

West Chester resident Beth Sininger says Dec. 14, 2010, was the worst day of her life. At age 52, she received the shocking news that her lingering stomach pain was actually stage 3 pancreatic cancer. 

"I thought maybe I had a bad case of acid reflux. Never in my wildest dreams did I think my diagnosis would be pancreatic cancer,” she recalls. "All I could think was: ‘I am going to die. I can’t leave my husband and family so soon.’” 

The day after her diagnosis was confirmed, Sininger’s UC Health primary care physician Sri Murthy, MD, arranged for her to meet with Syed Ahmad, MD, a UC Health surgical oncologist affiliated with the UC Cancer Institute. 

Sininger’s tumor was determined to be inoperable due to its proximity to the major arteries feeding blood to her lower body. Ahmad recommended beginning chemotherapy immediately and arranged for her to see medical oncologist Olugbenga Olowokure, MD, that afternoon—otherwise known as "Dr. Benga” by his patients. 

Although the prognosis seemed dismal at the time, Sininger says the support of her family, friends and "amazing medical team” gave her strength to give it her best fight. 

"How do you describe Dr. Benga? A force of nature, a huge ray of hope, a spiritual guide, the best doctor anyone could have when fighting pancreatic cancer … it’s really all of the above and more,” says Sininger. "With the exception of my husband, he is the most remarkable person I have ever met.”

Sininger says from the minute Olowokure met with her and "the chemo gang”—her husband, step-daughter, mother and best friend—he gave them hope and a path to follow.  

"He told us he would do everything possible to make surgery an option, but that I had to believe and keep a positive attitude. I had to keep my boxing gloves on all the time. So, I decided to fight. I kept my boxing gloves on—and so did my chemo gang—throughout all of 2011 and still do to this day,” she recalls. "Dr. Benga was my constant. He always made time to see me and my family, to answer our questions and walk us through the journey even when it got really hard.”

She began an aggressive chemotherapy regimen gemcitabine plus abraxane — each cycle of chemotherapy consisting of three weeks on, one week off—that continued for all of 2011. After the second  cycle of chemotherapy, she started a series of 31 radiation treatments with  Michelle Mierzwa , MD, a UC Health radiation oncologist who is also part of the UC Cancer Institute team. The combination of chemotherapy and radiation—also known as chemoradiation—is not typical if there is any suspicion of metastatic disease, but the multidisciplinary pancreatic cancer team agreed it was worth a try. She received gemcitabine-based chemoradiation, then resumed her previous chemotherapy regimen.

"You begin to live your life in months and quarters—tumor marker tests happen monthly, imaging tests are quarterly. It’s a continual up and down. Sometimes I was so tired I didn’t think I could get out of bed, let alone go to treatments. With the help of my chemo gang and an army of medical staff—nurses, PAs, doctors, techs—I made it through. I had to keep those boxing gloves on and keep fighting. I didn’t want to let my family or Dr. Benga down.”  

By September 2011, Sininger’s tumor count reached the normal range and remained there for the coming months. Together, Olowokure and Ahmad decided to send her to surgery. Ahmad gathered more than 100 biopsies of the organs and tissues surrounding the pancreas during her procedure to remove part of the pancreas and her spleen. All of the samples came back negative for signs of cancer. 

"Friday the 13 turned out to be a lucky day,” Sininger says, referring to her surgery date: Friday, Jan. 13, 2012. "I am currently cancer free—some of the best words in the English language. There are no guarantees that my cancer will not return, but I’m treating every precious day as a blessing. I owe so much to my medical army. I know I would not have heard these precious words without them and the love and support of my husband, parents, daughters and friends and prayers of so many people.” 

To learn more about the multidisciplinary gastrointestinal cancer team at the UC Cancer Institute, visit

For clinical trials, call 513-584-7698.

For appointment information, click here

Community Music Event Benefits Pancreatic Cancer Research
A portion of ticket and auction proceeds from the 2012 Rusty Ball will benefit the GIVEHOPE Pancreatic Cancer Research and Awareness Fund, a foundation established in honor of Beth Sininger. Together with BSI Engineering, GIVE HOPE provides funding support for an ongoing pancreatic cancer research pilot grant program at the UC Cancer Institute. The group awarded its first pilot grant in 2012 to Vladimir Bogdanov, PhD, a pancreatic cancer researcher affiliated with the UC Cancer Institute and UC College of Medicine.

The fifth annual Rusty Ball, hosted by the Rusty Griswold’s, will be held on November 10, 2012. Last year this event helped 119 local charities. GIVEHOPE was a beneficiary in 2011 and has been selected again for 2012.  
The nonprofit will receive a portion of ticket proceeds and certain auction items. GIVEHOPE will be auctioning two autographed guitars—one signed by the Doobie, the other by the band Chicago—two trips to Chicago and a two-flight glider package from the Caesar Creek Soaring Club. Learn more about the event and purchase tickets at Make sure to designate "GIVEHOPE” as your beneficiary. 

 back to list | back to top